For the readers interested in the stock health of Kintara Therapeutics Inc. (KTRA). It is currently valued at $0.25. When the transactions were called off in the previous session, Stock hit the highs of $0.1988, after setting-off with the price of $0.172. Company’s stock value dipped to $0.172 during the trading on the day. When the trading was stopped its value was $0.18.Recently in News on August 3, 2022, Kintara Therapeutics Enters Into Equity Purchase Agreement for Up to $20 Million with Lincoln Park Capital. Kintara Therapeutics, Inc. (Nasdaq: KTRA) (Kintara or the Company), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced it has entered into an equity purchase agreement for up to $20 million with Lincoln Park Capital Fund, LLC (LPC), a Chicago-based institutional investor. You can read further details here
Kintara Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.8400 on 04/11/22, with the lowest value was $0.1406 for the same time period, recorded on 05/12/22.
Kintara Therapeutics Inc. (KTRA) full year performance was -88.42%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Kintara Therapeutics Inc. shares are logging -84.70% during the 52-week period from high price, and 79.59% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.14 and $1.65.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 40614580 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Kintara Therapeutics Inc. (KTRA) recorded performance in the market was -65.25%, having the revenues showcasing -34.37% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 11.63M, as it employees total of 4 workers.
Analysts verdict on Kintara Therapeutics Inc. (KTRA)
During the last month, 0 analysts gave the Kintara Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.2605, with a change in the price was noted -0.07. In a similar fashion, Kintara Therapeutics Inc. posted a movement of -21.36% for the period of last 100 days, recording 3,254,292 in trading volumes.
Kintara Therapeutics Inc. (KTRA): Technical Analysis
Raw Stochastic average of Kintara Therapeutics Inc. in the period of last 50 days is set at 50.22%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 44.06%. In the last 20 days, the company’s Stochastic %K was 17.71% and its Stochastic %D was recorded 11.74%.
Let’s take a glance in the erstwhile performances of Kintara Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -65.25%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -57.30%, alongside a downfall of -88.42% for the period of the last 12 months. The shares increased approximately by -10.46% in the 7-day charts and went up by -30.51% in the period of the last 30 days. Common stock shares were lifted by -34.37% during last recorded quarter.